Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
ACCESSWIRE
14 May 2021, 04:05 GMT+10
HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the Company or INBP ) reports its financial results for the quarter ended March 31, 2021.
Revenue for the quarter ended March 31, 2021 was $17.1 million compared to $13.6 million for the quarter ended March 31, 2020, an increase of $3.4 million or 25.2%. The Company had operating income of $1.7 million and $1.0 million in the quarters ended March 31, 2021 and 2020, respectively.
Revenues for the nine-month period ended March 31, 2021 were $46.5 million compared to $39.2 million for the nine-month period ended March 31, 2020, an increase of $7.3 million or 18.6%. The Company had operating income for the nine-month period ended March 31, 2021 of $4.5 million compared to operating income of $2.6 million for the nine-month period ended March 31, 2020.
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
ACCESSWIRE
14 May 2021, 04:05 GMT+10
HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the Company or INBP ) reports its financial results for the quarter ended March 31, 2021.
Revenue for the quarter ended March 31, 2021 was $17.1 million compared to $13.6 million for the quarter ended March 31, 2020, an increase of $3.4 million or 25.2%. The Company had operating income of $1.7 million and $1.0 million in the quarters ended March 31, 2021 and 2020, respectively.
Revenues for the nine-month period ended March 31, 2021 were $46.5 million compared to $39.2 million for the nine-month period ended March 31, 2020, an increase of $7.3 million or 18.6%. The Company had operating income for the nine-month period ended March 31, 2021 of $4.5 million compared to operating income of $2.6 million for the nine-month period ended March 31, 2020.
Integrated BioPharma, Inc.: Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the Company or INBP ) reports its financial results for the quarter ended March 31, 2021.
Revenue for the quarter ended March 31, 2021 was $17.1 million compared to $13.6 million for the quarter ended March 31, 2020, an increase of $3.4 million or 25.2%. The Company had operating income of $1.7 million and $1.0 million in the quarters ended March 31, 2021 and 2020, respectively.
Revenues for the nine-month period ended March 31, 2021 were $46.5 million compared to $39.2 million for the nine-month period ended March 31, 2020, an increase of $7.3 million or 18.6%. The Company had operating income for the nine-month period ended March 31, 2021 of $4.5 million compared to operating income of $2.6 million for the nine-month period ended March 31, 2020.
Integrated BioPharma, Inc.: Integrated BioPharma Announces Launch of Investors Website
Integrated BioPharma Announces Launch of Investors Website
HILLSIDE, NJ / ACCESSWIRE / April 8, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the Company or INBP ) announces the launch of an updated investors website. As part of our efforts in supporting Integrated BioPharma, Inc. and its shareholders in the public markets, we are excited to announce, that effective today, INBP has launched an updated Investors Website providing current stock quotes, historical financial information, news and events and reactivating our email subscription alerts for our shareholders. stated the Co-Chief Executive Officers of the Company, Riva Sheppard and Christina Kay.
Integrated BioPharma Announces Launch of Investors Website newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.